Research in allergic diseases diagnosis and treatment

SCIENTIFIC PRODUCTION PRIOR TO DECEMBER 2019 IS LINKED TO THE GROUP "EPIDEMIOLOGY AND CLINICAL BIOSTATISTICS"

2023 Activity Indicators

4 national public competitive projects led: ISCIII, Instituto de Medicina Molecular Aplicada (IMMA)
8 private projects led
18 clinical studies led
1 competitive HR contract
36 publications
IF: 237.52
Q1 publications: 27 (75%)
D1 publications: 5 (14%)
1 award
Evaluators from medical sgencies and societies: 3 researchers
Members of editorial comittees: 2 researchers
1 patent issued in 5 countries in Europe with priority application P201331200 entitled "Method for the prognosis of the efficacy of oral immunotherapy for the treatment of allergy to cow's milk proteins"
1 clinical guide (PMID: 37517623)
9 visitors hosted and 18 days of stay:
- San Joan de Deu Hospital
- Santa Bárbara Hospital
- Granollers Hospital
- Juan Ramón Jiménez University Hospital Huelva
- Puerta de Hierro Hospital Majadahonda
- Jiménez Díaz Foundation
- Castellón General University Hospital
- 12 de Octubre University Hospital
- Tajo Hospital Madrid

Technical and clinical validation of the environmental exposure chamber for grass pollen completed. The biomarker search project is under development.
Intramural Project for the Study of Hereditary Hypertryptasia, Multidisciplinary Mastocytosis Unit, awarded.
Creation of a computer platform for the analysis of information obtained in peptide microarray assays through massive data analysis, using artificial intelligence "MicroarrAI Platform".
Launch of the Beta-lactam Allergy subprogram - within the PROA Program (Program for the optimization of the use of antibiotics). Healthcare Quality Program.
Launch and validation of the techniques for determining IgE, IgG and basophil activation assay using the Microarray and complement platform in hypersensitivity reactions to platinums and taxanes.